Cargando…

Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era

COVID-19 (Coronavirus Disease 2019), a life-threatening viral infection, is caused by a highly pathogenic virus named SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). Currently, no treatment is available for COVID-19; hence there is an urgent need to find effective therapeutic drugs to...

Descripción completa

Detalles Bibliográficos
Autores principales: Saini, Jasleen, Kaur, Pritpal, Malik, Naveen, Lakhawat, Sudarshan Singh, Sharma, Pushpender Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier GmbH. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491010/
https://www.ncbi.nlm.nih.gov/pubmed/36162150
http://dx.doi.org/10.1016/j.micres.2022.127206
_version_ 1784793204619476992
author Saini, Jasleen
Kaur, Pritpal
Malik, Naveen
Lakhawat, Sudarshan Singh
Sharma, Pushpender Kumar
author_facet Saini, Jasleen
Kaur, Pritpal
Malik, Naveen
Lakhawat, Sudarshan Singh
Sharma, Pushpender Kumar
author_sort Saini, Jasleen
collection PubMed
description COVID-19 (Coronavirus Disease 2019), a life-threatening viral infection, is caused by a highly pathogenic virus named SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). Currently, no treatment is available for COVID-19; hence there is an urgent need to find effective therapeutic drugs to combat COVID-19 pandemic. Considering the fact that the world is facing a major issue of antimicrobial drug resistance, naturally occurring compounds have the potential to achieve this goal. Antimicrobial peptides (AMPs) are naturally occurring antimicrobial agents which are effective against a wide variety of microbial infections. Therefore, the use of AMPs is an attractive therapeutic strategy for the treatment of SARS-CoV-2 infection. This review sheds light on the potential of antimicrobial peptides as antiviral agents followed by a comprehensive description of effective antiviral peptides derived from various natural sources found to be effective against SARS-CoV and other respiratory viruses. It also highlights the mechanisms of action of antiviral peptides with special emphasis on their effectiveness against SARS-CoV-2 infection.
format Online
Article
Text
id pubmed-9491010
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier GmbH.
record_format MEDLINE/PubMed
spelling pubmed-94910102022-09-21 Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era Saini, Jasleen Kaur, Pritpal Malik, Naveen Lakhawat, Sudarshan Singh Sharma, Pushpender Kumar Microbiol Res Article COVID-19 (Coronavirus Disease 2019), a life-threatening viral infection, is caused by a highly pathogenic virus named SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). Currently, no treatment is available for COVID-19; hence there is an urgent need to find effective therapeutic drugs to combat COVID-19 pandemic. Considering the fact that the world is facing a major issue of antimicrobial drug resistance, naturally occurring compounds have the potential to achieve this goal. Antimicrobial peptides (AMPs) are naturally occurring antimicrobial agents which are effective against a wide variety of microbial infections. Therefore, the use of AMPs is an attractive therapeutic strategy for the treatment of SARS-CoV-2 infection. This review sheds light on the potential of antimicrobial peptides as antiviral agents followed by a comprehensive description of effective antiviral peptides derived from various natural sources found to be effective against SARS-CoV and other respiratory viruses. It also highlights the mechanisms of action of antiviral peptides with special emphasis on their effectiveness against SARS-CoV-2 infection. Elsevier GmbH. 2022-12 2022-09-21 /pmc/articles/PMC9491010/ /pubmed/36162150 http://dx.doi.org/10.1016/j.micres.2022.127206 Text en © 2022 Elsevier GmbH. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Saini, Jasleen
Kaur, Pritpal
Malik, Naveen
Lakhawat, Sudarshan Singh
Sharma, Pushpender Kumar
Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era
title Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era
title_full Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era
title_fullStr Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era
title_full_unstemmed Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era
title_short Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era
title_sort antimicrobial peptides: a promising tool to combat multidrug resistance in sars cov2 era
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491010/
https://www.ncbi.nlm.nih.gov/pubmed/36162150
http://dx.doi.org/10.1016/j.micres.2022.127206
work_keys_str_mv AT sainijasleen antimicrobialpeptidesapromisingtooltocombatmultidrugresistanceinsarscov2era
AT kaurpritpal antimicrobialpeptidesapromisingtooltocombatmultidrugresistanceinsarscov2era
AT maliknaveen antimicrobialpeptidesapromisingtooltocombatmultidrugresistanceinsarscov2era
AT lakhawatsudarshansingh antimicrobialpeptidesapromisingtooltocombatmultidrugresistanceinsarscov2era
AT sharmapushpenderkumar antimicrobialpeptidesapromisingtooltocombatmultidrugresistanceinsarscov2era